Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-12

Clinical Trial Update: Peripheral Serotonin and Albinism

View source ↗

Summary

A clinical trial investigating the role of peripheral serotonin in oculocutaneous albinism; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Oculocutaneous Albinism | Status: RECRUITING